Total Payments
$9,219
2024 Payments
$1,645
Companies
62
Transactions
555
Medicare Patients
1,803
Medicare Billing
$263,526
Payment Breakdown by Category
Food & Beverage$8,285 (89.9%)
Education$934.10 (10.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,285 | 534 | 89.9% |
| Education | $934.10 | 21 | 10.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $714.26 | 56 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $544.48 | 34 | $0 (2024) |
| Amgen Inc. | $499.55 | 27 | $0 (2023) |
| Janssen Biotech, Inc. | $495.83 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $465.37 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $459.72 | 27 | $0 (2024) |
| Celgene Corporation | $457.91 | 31 | $0 (2024) |
| Eisai Inc. | $398.33 | 23 | $0 (2024) |
| Incyte Corporation | $367.82 | 21 | $0 (2024) |
| Genentech USA, Inc. | $350.33 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,645 | 96 | AstraZeneca Pharmaceuticals LP ($181.37) |
| 2023 | $2,002 | 107 | E.R. Squibb & Sons, L.L.C. ($192.48) |
| 2022 | $1,619 | 93 | Celgene Corporation ($209.88) |
| 2021 | $628.88 | 44 | E.R. Squibb & Sons, L.L.C. ($67.99) |
| 2020 | $358.99 | 21 | Amgen Inc. ($90.83) |
| 2019 | $501.36 | 26 | Astellas Pharma US Inc ($94.00) |
| 2018 | $991.37 | 59 | Janssen Biotech, Inc. ($140.19) |
| 2017 | $1,472 | 109 | Amgen Inc. ($218.70) |
All Payment Transactions
555 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| 12/14/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: NONE | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Oncology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/26/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.37 | General |
| 11/07/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: BioOncology | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Oncology | ||||||
| 11/01/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Oncology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 10/24/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Education | In-kind items and services | $49.99 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Oncology | ||||||
| 10/08/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $0.17 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: Hematology | ||||||
| 09/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.87 | General |
| 09/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 475 | 781 | $182,344 | $67,352 |
| 2022 | 6 | 434 | 748 | $169,479 | $62,762 |
| 2021 | 7 | 461 | 827 | $162,022 | $74,106 |
| 2020 | 9 | 433 | 742 | $189,720 | $59,306 |
Total Patients
1,803
Total Services
3,098
Medicare Billing
$263,526
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 425 | $89,675 | $32,980 | 36.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 101 | $31,613 | $11,854 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $18,372 | $6,865 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 89 | $12,816 | $3,807 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $7,900 | $3,081 | 39.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $6,912 | $2,652 | 38.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 25 | $5,450 | $2,530 | 46.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,174 | $2,507 | 34.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 16 | $2,432 | $1,076 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 437 | $93,518 | $34,603 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 85 | $26,775 | $10,045 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $16,352 | $5,928 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 94 | $13,630 | $4,511 | 33.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $10,404 | $4,181 | 40.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 40 | $8,800 | $3,495 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 195 | 493 | $83,810 | $39,869 | 47.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 83 | $19,920 | $10,240 | 51.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 67 | 67 | $18,626 | $7,461 | 40.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 64 | $14,336 | $5,617 | 39.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 40 | 42 | $12,432 | $4,772 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 61 | $6,710 | $3,451 | 51.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $6,188 | $2,697 | 43.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 362 | $82,032 | $23,374 | 28.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 51 | 80 | $24,824 | $7,534 | 30.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 40 | $17,282 | $6,928 | 40.1% |
About Loreta Garretson
Loreta Garretson is a Internal Medicine healthcare provider based in Egg Harbor Township, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124372677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Loreta Garretson has received a total of $9,219 in payments from pharmaceutical and medical device companies, with $1,645 received in 2024. These payments were reported across 555 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($8,285).
As a Medicare-enrolled provider, Garretson has provided services to 1,803 Medicare beneficiaries, totaling 3,098 services with total Medicare billing of $263,526. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Egg Harbor Township, NJ
- Active Since 11/06/2012
- Last Updated 03/03/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124372677
Products in Payments
- OPDIVO (Biological) $580.82
- IMBRUVICA (Drug) $561.80
- KEYTRUDA (Biological) $452.64
- Lenvima (Drug) $337.32
- VERZENIO (Drug) $221.53
- Pomalyst (Drug) $218.57
- JAKAFI (Drug) $208.30
- KISQALI (Drug) $202.78
- Enhertu (Drug) $180.61
- Nubeqa (Drug) $143.14
- FOTIVDA (Drug) $140.57
- Cabometyx (Drug) $140.28
- PADCEV (Biological) $122.85
- REBLOZYL (Biological) $117.69
- ERLEADA (Drug) $114.02
- TAGRISSO (Drug) $111.81
- IBRANCE (Drug) $104.82
- TECENTRIQ (Biological) $102.53
- BRUKINSA (Drug) $100.81
- Nplate (Biological) $99.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Egg Harbor Township
Dr. Devon Mckenzie, M.d, M.D
Internal Medicine — Payments: $12,955
Internal Medicine $12,955
Dr. Valmarie Ramos, Md, MD
Internal Medicine — Payments: $10,011
Internal Medicine $10,011
Neha Chawla
Internal Medicine — Payments: $7,443
Internal Medicine $7,443
Ephrem Hector Paradela, Md, MD
Internal Medicine — Payments: $6,846
Internal Medicine $6,846
Nishil Dalsania, M.d, M.D
Internal Medicine — Payments: $6,028
Internal Medicine $6,028
Neha Patel, M.d, M.D
Internal Medicine — Payments: $4,260
Internal Medicine $4,260